Skeletal muscle dysfunction in chronic obstructive pulmonary disease. What we know and can do for our patients

A Jaitovich, E Barreiro - American journal of respiratory and critical …, 2018 - atsjournals.org
Skeletal muscle dysfunction occurs in patients with chronic obstructive pulmonary disease
(COPD) and affects both ventilatory and nonventilatory muscle groups. It represents a very …

[HTML][HTML] Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings

J Gea, S Pascual, C Casadevall… - Journal of thoracic …, 2015 - ncbi.nlm.nih.gov
Respiratory and/or limb muscle dysfunction, which are frequently observed in chronic
obstructive pulmonary disease (COPD) patients, contribute to their disease prognosis …

Respiratory sarcopenia: a position paper by four professional organizations

S Sato, S Miyazaki, A Tamaki… - Geriatrics & …, 2023 - Wiley Online Library
We defined respiratory sarcopenia as a coexistence of respiratory muscle weakness and
decreased respiratory muscle mass. Although respiratory muscle function is indispensable …

[HTML][HTML] Nutritional state and COPD: Effects on dyspnoea and exercise tolerance

A Tramontano, P Palange - Nutrients, 2023 - mdpi.com
Chronic Obstructive Pulmonary Disease (COPD) is a disease that is spreading worldwide
and is responsible for a huge number of deaths annually. It is characterized by progressive …

Effects of home-based breathing exercises in subjects with COPD

Y Lu, P Li, N Li, Z Wang, J Li, X Liu, W Wu - Respiratory care, 2020 - rc.rcjournal.com
BACKGROUND: We sought to investigate the effects of home-based breathing exercises on
pulmonary function, respiratory muscle strength, exercise capacity, dyspnea, and health …

Insulin‐like growth factor‐1 signaling in lung development and inflammatory lung diseases

Z Wang, W Li, Q Guo, Y Wang, L Ma… - BioMed research …, 2018 - Wiley Online Library
Insulin‐like growth factor‐1 (IGF‐1) was firstly identified as a hormone that mediates the
biological effects of growth hormone. Accumulating data have indicated the role of IGF‐1 …

[HTML][HTML] Muscle atrophy in chronic obstructive pulmonary disease: molecular basis and potential therapeutic targets

E Barreiro, A Jaitovich - Journal of thoracic disease, 2018 - ncbi.nlm.nih.gov
Patients with chronic obstructive pulmonary disease (COPD) experience several systemic
manifestations such skeletal muscle dysfunction with and without muscle mass loss …

Why and how limb muscle mass and function should be measured in patients with chronic obstructive pulmonary disease

A Nyberg, D Saey, F Maltais - Annals of the American Thoracic …, 2015 - atsjournals.org
Impaired limb muscle function is a common occurrence in patients with chronic obstructive
pulmonary disease (COPD), and it negatively influences exercise tolerance, quality of life …

Severity of COPD and its relationship with IL-10

BSA Silva, FS Lira, D Ramos, JS Uzeloto, FE Rossi… - Cytokine, 2018 - Elsevier
Background The present study was designed to compare inflammatory and metabolic
responses according to severity of airflow among patients with COPD and to verify the …

[HTML][HTML] Diaphragm dysfunction and rehabilitation strategy in patients with chronic obstructive pulmonary disease

Y Cao, P Li, Y Wang, X Liu, W Wu - Frontiers in Physiology, 2022 - frontiersin.org
Chronic obstructive pulmonary disease (COPD) affects the whole body and causes many
extrapulmonary adverse effects, amongst which diaphragm dysfunction is one of the …